Introduction
L-Glutamate (Glu) is the major excitatory amino acid in the mammalian central nervous system (CNS), and the activation of Glu receptors by extracellular Glu is a tightly regulated process as high extracellular Glu concentrations lead to an excitotoxic injury cascade and neuronal injury (Beart and O'Shea, 2007) . The concentration and half-life of Glu in the synapse is regulated by sodium-dependent uptake via excitatory amino acid transporters (EAATs), mostly astrocytic EAATs with EAAT2 and to a lesser extent EAAT1, responsible for the bulk of Glu uptake in the CNS (Rothstein et al., 1996 , Tanaka et al., 1997 . EAATs are vital to maintaining Glu homeostasis and EAAT dysfunction or loss of EAAT expression has been linked to various neurodegenerative diseases including amyotrophic lateral sclerosis, epilepsy, cerebral ischemia, Alzheimer's disease, Parkinson's disease and
Huntington's disease O'Shea, 2007, Sheldon and Robinson, 2007) . While Glu uptake is energetically costly, EAATs are able to drive Glu uptake against the concentration gradient by utilizing the strong electrochemical gradient generated by the Na + /K + -ATPase (Beart and O'Shea, 2007) . Evidence of interactions between EAATs and the Na + /K + -ATPase has begun to emerge (Rose et al., 2009 ) and recent molecular studies support the compartmentalization of these proteins (Genda et al., 2011 , Bauer et al., 2012 in a macromolecular complex whose function is strongly dependent on energy demands.
Optimal EAAT cell surface expression is vital for Glu uptake and Glu homeostasis, particularly when extracellular Glu levels are high. In astrocytes, the majority of EAAT protein is expressed in the plasma membrane (>80% for EAAT2), with evidence for small intracellular pools of EAAT protein and trafficking of transporters (Susarla et al., 2004 , Sheldon et al., 2006 , Benediktsson et al., 2012 . While there are a number of factors that are known to affect the regulation of EAAT expression at the cell surface, this area still remains poorly understood. Protein trafficking is likely to be involved in the homeostatic regulation of EAAT activity, although it is difficult to discriminate between internalization, trafficking and subsequent changes in level of EAAT cell surface expression (Duan et al., 1999 , Tai et al., 2007 versus changes in the catalytic efficiency of the transporter (Gonzalez et al., 2002 , Adolph et al., 2007 . EAAT activity and expression are regulated upon changes in astrocytic morphology. Astrocytes undergo substantial cytoskeletal reorganization both during development and in response to injury exemplified by astrocyte stellation and reactive astrogliosis (Ridet et al., 1997, Maragakis and Rothstein, 2006) . Indeed, evidence for the strong relationship between astrocytic morphology and EAAT activity has recently begun to emerge with, in general a loss of EAAT2 and preservation of EAAT1 associated with reactive changes (Schlag et al., 1998 , Bendotti et al., 2001 , O'Shea et al., 2006 , Lau et al., 2010 , Lau et al., 2011 , Lau et al., 2012 .
In recent work we found that pharmacological treatments (e.g. Rho kinase inhibition) that led to alterations in astrocytic morphology elevated expression at the cell surface compartments and a consequent increase in transporter V max (O'Shea et al., 2006 , Lau et al., 2011 . In this study we investigate the reverse event i.e. the response and recovery from Glu transporter inhibition. Rottlerin, a compound with a variety of effects including inhibition of PKC δ, was chosen since it has been shown to inhibit EAAT1 activity, reducing transport V max following inducing EAAT internalisation and to reduce EAAT1 cell surface expression in astrocytic cultures (Susarla and Robinson, 2003) . In this study we investigate the effect of Glu transport on astrocyte morphology and EAAT distribution. Using primary cultured mouse astrocytes expressing both EAAT1 and EAAT2 we report for the first time that in addition to inhibiting EAAT activity, rottlerin causes changes in EAAT distribution and cytoskeletal rearrangement. In addition we provide evidence that rottlerin inhibition is rapidly reversible and enhanced by co-treatment with the Na + ionophore monensin. Furthermore, the mechanism of loss of EAAT activity and its recovery was not due to trafficking but rather rottlerin acting as a metabolic un-coupler affecting the function of the Na + /K + -ATPase with consequent inhibition of EAAT activity. This study provides new evidence of the link between EAAT activity and astrocytic morphology and supports the importance of the interdependent relationship between Glu uptake and the Na + /K + -ATPase (Danbolt, 2001 , Beart and O'Shea, 2007 , Sheldon and Robinson, 2007 .
Experimental Procedure

Primary Astrocyte Cultures
Primary astrocytes were cultured from the brains of 1.5 d C57Bl6 mice as previously described (O'Shea et al., 2006) . All experimentation received ethical approval and was undertaken according to the guidelines of the NHMRC (Australia). Briefly, forebrains of mice were removed, placed in ice cold HBSS solution and chemically digested in a trypsin solution with trituration using a 15 gauge needle. The homogenate was centrifuged and resultant pellet re-suspended in astrocytic medium (AM) prepared from DMEM (Gibco TM Invitrogen Corporation, Melbourne, Australia) containing 10% heat inactivated certified fetal bovine serum (FBS), 100 U/ml penicillin/streptomycin and 0.25% (v/v) Fungizone TM , preheated to 37°C at a volume of 5 ml per brain and plated at 10 ml per 75 cm 2 flask (NUNC, Copenhagen, Denmark). Cells were plated at 10 ml/75 cm 2 flask (2 brains/flask) and maintained in a humidified incubator supplied with 5% CO 2 at 37°C. Medium was changed twice weekly by aspiration and replacement with fresh pre-heated AM. Sub-culturing generated "secondary" cultures and cells were seeded onto plates with or without glass coverslips (1 x 10 4 cells/cm -2 ) at 10 div. A full media change was performed twice weekly with pre-heated AM to remove non-adherent cells. Drug treatments were performed when astrocytes became confluent at 22 div (12 div after subculturing). For all drug treatments, stock solutions were prepared in DMSO (Sigma-Aldrich, Sydney, Australia) and diluted using pre-heated AM maintained at a final volume of 0.5 ml/well. Drug concentrations were determined in preliminary dose response studies or from previous studies in the literature.
[ 3 H]D-Aspartate Uptake
The activity of Glu transport was determined by monitoring the uptake of (Apricò et al., 2004 (GraphPad, San Diego, USA).
Cell Viability
Cellular viability was assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; an index of mitochondrial function; Sigma-Aldrich) reduction assay (Lau et al., 2011) . Cells were incubated for 30 min at 37°C, MTT was aspirated, DMSO (SigmaAldrich) was added and cell viability determined colometrically (570 nm) on a Bio-Rad Benchmark Plus microplate spectrophotometer (Bio-Tek Instruments, Inc., Winooski, USA).
Immunocytochemistry
Cells on glass coverslips were fixed with paraformaldehyde (4%) in phosphate-buffered saline (PBS, pH 7.4), washed extensively and blocked in PBS containing 10% normal donkey serum (NDS) and 0.3% TX-100 at RT for 1 h. Cells were then washed rapidly with cold PBS, and incubated with selected primary antibodies (EAAT1 anti A522-541, 1:1500, Dr. Niels C. Fluorescence was visualized and digital images were acquired using an Olympus FluoView 1000 inverted confocal microscope with compatible software. Image analysis was performed using ImageJ software (obtained from the NIH website: http://rsb.info.nih.gov/ij) as described previously (Lau et al., 2011 ).
Biotinylation of Cell Surface Proteins, Protein Determination and Western blot Analysis
These procedures have been described previously (O'Shea et al., 2006) . Samples were pooled from 6 wells (n = 3 replicates) and total cell protein concentration determined with the BioRad Dc Assay Kit (Sydney, Australia) according to the manufacturer's specifications.
Western blots were performed where equal volumes of all three fractions (total, intracellular and cell surface) were loaded onto gels and membranes were incubated with primary antibodies (EAAT1 anti-A522, 1:15,000; GLT-1 1:10,000) at 4°C, overnight. The following day, membranes were washed and incubated with IRDye conjugated secondary antibodies (LiCor) and imaged using the Odyssey Classic near infrared detection system. Blots were quantified by taking the mean gray value of EAAT1 and EAAT2 bands normalised to β-actin level after subtracting background intensity.
Rubidium (
86 Rb + ) Uptake 86 Rb + uptake into astrocytes was performed as previously described with minor adaptations (Aschner et al., 1990) . At the completion of drug treatments, astrocytes were incubated with 
Statistical analysis
Data were analyzed using GraphPad Prism 5 (GraphPad Software, San Diego, CA). All comparisons were conducted by student t-tests, and ANOVA with Tukey or Dunnett multiple comparisons test where indicated, and a value of p < 0.05 was considered statistically significant. Values are expressed as the mean ± SEM and are from replicate observations (typically 3-6) from independent experiments.
Results
Rottlerin induces astrocyte stellation
Immunocytochemistry in concert with confocal microscopy was used to determine changes in cellular morphology and EAAT expression and localization following treatment with rottlerin. In untreated cells, GFAP labelled both the cell body and major processes of the cell, with cell bodies appearing round and uniform in shape ( Figure 1A ). The pattern of localization seen with F-actin immunoreactivity revealed a sponge-like distribution, with strong fluorescence displaying a ring around the membrane of the cell body, together with a thick mesh of stress fibres extending across the diameter of the cell ( Figure 1B ). Strong EAAT1 immunoreactivity was localized to the membrane of the cell body, while weaker EAAT1 labelling was present on processes that were immunoreactive for GFAP ( Figure 1A and 1B). EAAT2 had a punctate appearance, which was observed throughout the cell, being less restricted to the cell body ( Figure 1A and 1B).
Treatment of astrocytes with rottlerin (100 µM) exerted a time-dependent effect on astrocytic morphology. Rottlerin (1 and 6 h) caused an apparent increase in GFAP expression, with cells displaying a more stellate morphology when compared to untreated cells ( Figure 1A ).
After 24 h treatment with rottlerin, GFAP-immunoreactive processes were sporadically distributed. Quantitative image analysis was performed and revealed a significant increase in GFAP intensity at 1 h ( Figure 1C ). After rottlerin treatment rhodamine-phalloidin staining was more significantly associated with the cell body showing redistribution of F-actin and disappearance of stress fibres ( Figure 1B ). Image analysis identified an increase in F-actin intensity at 6 h ( Figure 1C ). EAAT1 and EAAT2 both appeared to become re-organized with the changes in cytoskeletal arrangement as cells adopted a more stellate morphology. EAAT1
immunoreactivity was more visible around GFAP-positive cell bodies and processes ( Figure 1A ). Increased co-localization between EAAT2 with GFAP was apparent ( Figure 1A ).
Rottlerin did not induce overlap between EAAT1 and F-actin ( Figure 1B ) but rottlerin induced some co-localization between EAAT2 and F-actin ( Figure 1B ). Reductions in GFAP and F-actin observed at 24 h are likely to be due to a minor component cell death as a reduced number of cells were observed at this time point. These data suggested that rottlerin induces cytoskeletal rearrangement including subsequent changes in EAAT distribution.
Rottlerin reduces EAAT activity and alters EAAT kinetics in a reversible manner
Exposure of cultured astrocytes to rottlerin (100 µM) for 0 -24 h produced time-dependent decreases in EAAT activity as measured by the transport of [ 3 H]-D-Asp with significant decreases found as early as 0.5 h (64 ± 10% of control, P < 0.01) ( Figure 2A ). The decrease in uptake appeared to plateau between 1 and 4 h, although a further decrease in activity was observed at 24 h (16 ± 2.2% of control, P < 0.001). The t 1/2 for inhibition of Glu transport was determined to be ~50 min ( Figure 2A ). This reduction in activity was not due to changes in cell viability ( Figure 2B ). Alterations in EAAT activity could occur through changes in the affinity (K m ) of the transporter and/or changes in the rate of transport (V max ), so kinetic analysis was performed ( Figure 2C ). Treatment with rottlerin caused a significant decrease in the V max (control 55 ± 36, 1 h 10 ± 3.3, 24h 5 ± 3.7 pmol/mg protein/min P < 0.05), with no significant effect on the K m of the transporter (control 44 µM (13-150; 95% confidence intervals), 1 h 20 µM (10-39), 24h 9.6 µM (1.8-52)). The decrease in V max was very similar at both 1 and 24 h. The decrease in V max represents a decrease in the rate of transport that could arise from a pool of inactive transporters at the cell surface or from a decrease in the number of functional transporters present at the cell surface consequent to EAAT internalization Robinson, 2003, Gonzalez et al., 2005) .
We next investigated the rate of recovery of Glu uptake following removal of rottlerin:
astrocytes were treated with rottlerin (100 µM, 6 h) after which the drug was removed (0 -20 h) by washing cells three times with astrocytic medium. EAAT activity was analyzed over the next 20 h. Cells treated with rottlerin showed a significant decrease in [ 3 H]-D-Asp uptake at 6 h (26 ± 7.7% of control, P < 0.0001) ( Figure 2D ). Once rottlerin was removed,
Asp uptake returned to control levels with a rapid early increase in activity seen at 0.25 h post treatment (to 54 ± 11% of control), followed by a slower return to levels similar to control by 2 h following removal of rottlerin (71 ± 7% of control, t½ = 174 min). There was no change in cell viability following rottlerin treatment or during the post-treatment stage (results not shown). Thus these findings indicated that rottlerin reversibly inhibited EAAT activity via changes in the rate of Glu transport and not via changes in affinity of the transporters.
Alterations in cell surface EAAT expression after rottlerin treatment do not parallel EAAT activity
The biotinylation of cell surface proteins was used together with Western blotting to examine the effect of rottlerin treatment and withdrawal on expression of EAAT1 ( Significant changes in levels of total, membrane or intracellular EAAT1 expression were not observed with rottlerin treatment (6 h) or following rottlerin removal (6 h, Figure 3 A-F).
Levels of total EAAT2 protein increased by approximately 2.7 fold in recovery cells compared to untreated cells ( Figure 3H , P<0.01) There was no statistical difference in intracellular EAAT2 levels compared to control ( Figure 3J ). Paradoxically, despite decreased EAAT activity at this timepoint, there was a 2.6 fold increase in EAAT2 expression at the cell surface of rottlerin-treated cells ( Figure 3L , P<0.05). In rottlerin recovery cells, EAAT2
protein levels at the cell surface remained increased (2.8 fold) compared to untreated cells ( Figure 3L , P<0.05). Overall our evidence of elevated EAAT expression at the cell surface when Glu transport was decreased is indicative of the recruitment of alternate mechanisms.
Interference with trafficking pathways fails to block recovery of EAAT activity
To further investigate the possible involvement of trafficking and internalisation pathways in the recycling of EAATs to the cell surface, a number of commonly used inhibitors were employed to target specific stages of the anterograde pathway (Servitja et al., 1999 , Kittler et al., 2000 , Casale et al., 2005 . Cells were treated with rottlerin alone or in the presence of inhibitors to determine if the inhibitor could alter the recovery of EAAT activity observed following rottlerin removal. Brefeldin A (50 µM, 24 h, Figure 4A ) and nocadazole (10 µM, 1 h Figure 4B ), which block ER to Golgi and Golgi trafficking, respectively, had no effect on the recovery of EAAT activity following rottlerin removal. Monensin (100 µM, 2 h, Figure   4C ), which amongst other actions, interferes with the trans-Golgi region and endosomal trafficking (Casale et al., 2005) , increased the rate of recovery of EAAT activity (t ½ = 13.38 mins, Figure 4C , P<0.01) with significant effects seen at 0.25, 1 and 2 h. Changes in cell viability were not observed with any treatment (data not shown).
In related experiments, astrocytes were treated with hypertonic concentrations of sucrose (0.45 M, 0.5 h) to determine if the reduction in EAAT activity observed with rottlerin treatment could be blocked by inhibiting endocytosis. Treatment with rottlerin caused a significant decrease in [ 3 H]-D-Asp uptake (~35%, P<0.01), while sucrose treatment had no effect ( Figure 4D ). Sucrose was unable to block the inhibitory effects of rottlerin when added together with rottlerin ( Figure 4D , ~35%, P<0.01). Although however minor reductions in cell viability were observed with both sucrose (~10%, P<0.01) and rottlerin + sucrose (~15%, P<0.001) treatments ( Figure 4E ), the effects on EAAT activity were not associated with changes in cell viability. These data indicated that rottlerin-induced changes in EAAT activity were not due to intracellular trafficking of transporters away from the cell surface and further suggested another mechanism of inhibition.
Rottlerin inhibits the Na + /K + -ATPase which recovers following rottlerin removal
The ability of rottlerin to act as a metabolic uncoupler, together with the evidence that monensin, a Na + ionophore (Pressman and Fahim, 1982) , improves the recovery of EAAT activity following rottlerin treatment led us to consider the novel hypothesis that Na MTT assay was performed to determine the effect of treatment on cell viability and revealed no significant effect of any treatment on the viability of the cells ( Figure 5B ).
Primary astrocyte cultures were treated with rottlerin (100 µM, 6 h) or rottlerin + monensin (100 µM, 2 h) and 86 Rb + uptake was determined ( Figure 5C ). Cells treated with rottlerin alone showed a significant decrease in 86 Rb + uptake at the treated time-point (zero recovery) of ~50% (P<0.05). Following rottlerin removal, Na suggesting that treatments had no effect on cell viability over the 6 h recovery period. A small but lost-lasting decrease (10%) in total ATP levels was seen in both rottlerin treated and recovery cells ( Figure 5E ): an effect which matched the time-course of recovery of Glu uptake and elevation of cell surface expression of EAAT2. In summary, rottlerin reversibly inhibited the activity of the Na 
Discussion
Loss of Glu transport linked to cytoskeletal changes and Na
+ /K + -ATPase inhibition
Under pathological conditions astrocytic EAATs display decreased activity together with reactive astrogliosis (Beart & O'Shea, 2007) and in experimental models genetic or pharmacological down-regulation of EAAT activity results in altered Glu metabolism and astrocytic function with neuronal damage (Danbolt, 2001; Beart & O'Shea, 2007; Sheldon & Robinson, 2007) . Previous work from our group has greatly advanced the case for a link between changes in astrocytic morphology and EAAT activity (O'Shea et al., 2006 , Lau et al., 2010 , Lau et al., 2011 supporting earlier evidence (Schlag et al., 1998 , Hughes et al., 2004 , Zhou and Sutherland, 2004 . We demonstrate for the first time that rottlerin causes changes in astrocytic morphology typical of development of a reactive phenotype in astrocytes. Changes in astrocytic morphology consistent with stellation were found, including elongation of cells, increased GFAP immunoreactivity, loss of F-actin stress fibres and condensation of labelling around the cell body (Tsai et al., 2006) . Moreover, we showed that rottlerin caused a rapid decrease in EAAT activity, an affect that was fully reversible following rottlerin withdrawal and not related to cellular toxicity, but due to an altered cytoskeleton and inhibition of Na + /K +-ATPase activity.
Alterations in transporter activity are commonly associated with changes in the expression and/or localization of the transporter protein in particular, loss of transporter function is often associated with a reduction in the cell surface expression of transporter protein (Sotnikova et al., 2006) . Indeed, recent time-lapse evidence shows accumulation of EAAT2 clusters in astrocytic processes during neuronal activation and subsequent reduction in expression and changes in localization during inactivation states (Benediktsson et al., 2012) . We, like others (Martinez-Villarreal et al., 2012) , have observed such vesicular-like clusters for EAAT2, including after rottlerin treatment (data not shown). For EAATs many of these issues remain to be resolved and while there is evidence for EAAT molecular complexes (Bauer et al., 2012; Genda et al., 2011; Rose et al., 2009) , there is a relative scarcity of information on the regulation of their cell surface expression and trafficking (Beart & O'Shea, 2007; Sheldon & Robinson, 2007) .
Homeostatic increases in EAAT2 expression with Glu transport inhibition
Previously, under conditions where Glu uptake was compromised we found evidence for a homeostatic mechanism maintaining EAAT expression in the presence of altered astrocytic morphology (Lau et al., 2010; Zagami et al., 2009) . In primary cultures of rat astrocytes, rottlerin had inhibitory effects on EAAT1 activity, decreased EAAT1 cell surface expression and increased EAAT degradation (Susarla and Robinson, 2003) . Our primary astrocytic cultures of astrocytes were more mature and expressed both EAAT1 and EAAT2, allowing us to explore the effects of rottlerin on both transporters. Data here support previous studies showing the inhibitory effect of rottlerin on the activity of the astrocytic transporters (~50% after 50 min, 100 µM) and also the reduction in the rate of transport. However, biotinylation and western blotting revealed that rottlerin treatment was not associated with EAAT2 or EAAT1 decreases in the cell surface fraction. Paradoxically, rottlerin caused a large increase in cell surface EAAT2. This result was surprising as elevated levels of total EAAT protein or an increase in EAAT protein at the cell surface activity are often associated with an upregulation in EAAT activity (Davis et al., 1998 , Robinson, 2002 . Removal of rottlerin restored EAAT activity, but was accompanied by maintenance rather than a further elevation of EAAT expression at the cell surface. Thus the inhibition caused by rottlerin is not due to a loss of transporter expression at the cell surface but rather a loss of function. These findings were further supported by evidence that drugs targeting the endoplasmic reticulum, Golgi apparatus and endosomes (brefeldin, nocadazole, sucrose), intracellular compartments classically linked to trafficking and internalization, did not alter rottlerin-induced inhibition of Glu uptake or recovery. Indeed, Susarla and Robinson (2003) reported that rottlerin had no effect on the transferrin receptor and concluded that its action on EAAT1 was not mediated via classical Rab recycling mechanisms. Our data suggest that, under the conditions employed, the inhibition of EAAT activity by rottlerin is not due to EAAT trafficking.
During our analysis of possible mechanisms linked to protein trafficking and internalization, we observed that monensin significantly enhanced recovery of EAAT activity following rottlerin withdrawal. Although monensin was employed as an inhibitor of trafficking from the Golgi (Mollenhauer et al., 1990) , it also has a role as a Na + ionophore (Pressman, 1976) . The ability of monensin to regulate Na + and other monovalent cations might underlie its ability to increase the rate of EAAT recovery following rottlerin removal. EAAT activity is exquisitely dependent on ionic gradients and the Na ATPase leads to a reduction in Glu uptake and transporter reversal (Gemba et al., 1994 , Li et al., 1999 , Rossi et al., 2000 as well as an increase in vulnerability of neurons to Glu toxicity (Novelli et al., 1988 , Kohmura et al., 1990 , Brines et al., 1995 . Therefore we investigated whether rottlerin affected the Na Rottlerin, often considered a PKC δ inhibitor, is recognised to have numerous pharmacological actions (Bain et al., 2007 , Soltoff, 2007 . Its actions include an ability to uncouple mitochondrial respiration from oxidative phosphorylation by lowering the H + gradient, increasing O 2 consumption and reversing the action of ATP synthase, resulting in a loss of ATP (Soltoff, 2001 ) and depolarization of the mitochondrial membrane potential (Liao et al., 2005) . We show that treatment of astrocytes with rottlerin inhibited Na the loss of Glu uptake with rottlerin treatment to a reduction in EAAT1 cell surface expression, however as discussed above, there was no evidence here for such an effect using careful biochemical analyses which showed a key role for EAAT2.
Monensin suggests role for Na + in EAAT inhibition
We show for the first time that removal of rottlerin rapidly reverses the inhibition on the (Mollenhauer et al., 1990 ).
Conclusions
This study provides significant new evidence of the relationship between Na + , the Na • Rottlerin induces cytoskeletal changes consistent with astrocyte activation and stellation.
• Rottlerin inhibits glutamate uptake via a decreased rate of transport, not a loss in cell surface glutamate transporters.
• Loss of glutamate uptake was reversible and enhanced by co-treatment with monensin.
• Na + /K + -ATPase activity and ATP levels are also reduced with exposure to rottlerin.
• Recovery of Na + /K + -ATPase activity preceded Glu uptake rescue supporting partial uncoupling of these processes.
